HOPRUVI Trademark

Trademark Overview


On Monday, January 13, 2020, a trademark application was filed for HOPRUVI with the United States Patent and Trademark Office. The USPTO has given the HOPRUVI trademark a serial number of 79279302. The federal status of this trademark filing is IR CANCELLED - NO TRANSFORMATION FILED as of Friday, June 26, 2020. This trademark is owned by Glaxo Group Limited. The HOPRUVI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines
hopruvi

General Information


Serial Number79279302
Word MarkHOPRUVI
Filing DateMonday, January 13, 2020
Status401 - IR CANCELLED - NO TRANSFORMATION FILED
Status DateFriday, June 26, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateFriday, March 20, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Wednesday, April 29, 2020IRREGULARITY FROM IB EXAMINED BY MPU
Tuesday, April 28, 2020IRREGULARITY ON REFUSAL FROM IB
Sunday, April 5, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, April 5, 2020REFUSAL PROCESSED BY MPU
Friday, April 3, 2020NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Thursday, April 2, 2020DEATH OF INTERNATIONAL REGISTRATION
Thursday, March 19, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, March 18, 2020NON-FINAL ACTION WRITTEN
Sunday, March 15, 2020ASSIGNED TO EXAMINER
Saturday, February 29, 2020APPLICATION FILING RECEIPT MAILED
Tuesday, February 25, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 24, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, February 20, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB